Record Information
Version2.0
StatusDetected and Quantified
Creation Date2021-05-14 19:37:24 UTC
Update Date2025-10-07 16:04:28 UTC
Metabolite IDMMDBc0001404
Metabolite Identification
Common NameBrevicompanine E
DescriptionBrevicompanine E is a secondary metabolite belonging to the class of alkaloids. This compound has garnered attention for its biological activity, particularly in the context of neuroinflammation. Research indicates that Brevicompanine E reduces lipopolysaccharide-induced production of proinflammatory cytokines and enzymes in microglia by inhibiting the activation of activator protein-1 and nuclear factor-kappaB, which are critical pathways in inflammatory responses (PMID:19815299 ). Additionally, it has been isolated from a deep ocean sediment-derived fungus, Penicillium sp., and has been shown to inhibit the production of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) in microglia following lipopolysaccharide stimulation (PMID:19815299 ). These findings suggest that Brevicompanine E may have potential therapeutic applications in conditions characterized by neuroinflammation.
Structure
SynonymsNot Available
Molecular FormulaC25H33N3O3
Average Mass423.557
Monoisotopic Mass423.252191935
IUPAC Name(1R,4S,7S,9R)-6-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-16-propanoyl-2,5,16-triazatetracyclo[7.7.0.0^{2,7}.0^{10,15}]hexadeca-5,10,12,14-tetraen-3-one
Traditional Name(1R,4S,7S,9R)-6-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-16-propanoyl-2,5,16-triazatetracyclo[7.7.0.0^{2,7}.0^{10,15}]hexadeca-5,10,12,14-tetraen-3-one
CAS Registry NumberNot Available
SMILES
[H][C@@]12C[C@]3(C4=CC=CC=C4N(C(=O)CC)[C@@]3([H])N1C(=O)[C@]([H])(CC(C)C)N=C2O)C(C)(C)C=C
InChI Identifier
InChI=1S/C25H33N3O3/c1-7-20(29)27-18-12-10-9-11-16(18)25(24(5,6)8-2)14-19-21(30)26-17(13-15(3)4)22(31)28(19)23(25)27/h8-12,15,17,19,23H,2,7,13-14H2,1,3-6H3,(H,26,30)/t17-,19-,23-,25+/m0/s1
InChI KeyFKIMAYNINSCCGK-CKRMUJODSA-N